Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
iohexol + magnesium citrate is a combination regimen used for bowel preparation and fecal tagging in patients undergoing computed tomographic (CT) colonography. Iohexol is a non-ionic, water-soluble iodinated contrast agent that, when ingested orally, opacifies residual stool and fluid (fecal tagging), allowing for better differentiation between fecal material and colonic polyps or masses during imaging. Magnesium citrate is a saline osmotic laxative that increases fluid in the small intestine and promotes bowel evacuation. Together, they provide a cleansed and tagged colon, which enhances the accuracy of electronic subtraction software and improves the overall diagnostic quality of the imaging procedure for the detection of colorectal carcinoma and polyps.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on iohexol + magnesium citrate.